NUDT22 promotes cancer growth through pyrimidine salvage and the TCA cycle
Melanie Walter(The University of Sydney), Patrick Herr(Immodulon Therapeutics (United Kingdom)), Bishoy Hanna(Nepean Hospital), Florian Mayr(Queen's University Belfast), Oliver Mortusewicz(Science for Life Laboratory), Thomas Helleday(Science for Life Laboratory), Victoria Cookson(University of Bern)
Cited by 0
Related Papers
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass
|Diabetologia|2010|313
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
|Nature Communications|2017|278
Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients
|Orphanet Journal of Rare Diseases|2013|188
Porcupine-mediated lipidation is required for Wnt recognition by Wls
|Developmental Biology|2011|185
Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase
|The Journal of Cell Biology|2010|165